Table 4.
Body mass index | Glucose | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
n/N* | Hazard ratio** | 95% CI** | P | n/N* | Hazard ratio** | 95% CI** | P | |||
CDAH | 19/3,200 | 1.53 | 1.11 | 2.13 | 0.01 | N/A | ||||
Young Finns Study | 19/3,572 | 0.99 | 0.63 | 1.55 | 0.96 | 6/1,802 | 1.18 | 0.67 | 2.08 | 0.58 |
U.S. cohorts *** | 312/13,832 | 1.11 | 1.00 | 1.24 | 0.04 | 110/5,887 | 1.23 | 1.01 | 1.49 | 0.04 |
Analyses adjusted for age and sex and study cohort,
n (cancer deaths) / N (number of censored)
Per one standard deviation increase
U.S. cohorts included BHS, NGHS, Minnesota, and PLRS with data on childhood glucose available